Lopressor and Hepatitis aggravated - a phase IV clinical study of FDA data

Summary:

Hepatitis aggravated is reported as a side effect among people who take Lopressor (metoprolol tartrate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lasix, and have Osteoporosis.

The phase IV clinical study analyzes which people have Hepatitis aggravated when taking Lopressor. It is created by eHealthMe based on reports of 32,072 people who have side effects when taking Lopressor from the FDA, and is updated regularly.

What is Lopressor?

Lopressor has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 33,152 Lopressor users. Check the latest studies of Lopressor.

What is Hepatitis aggravated?

Hepatitis aggravated is found to be associated with 1,149 drugs and 433 conditions by eHealthMe. Check the latest studies of Hepatitis aggravated.

On Jul, 14, 2026

32,072 people reported to have side effects when taking Lopressor.
Among them, 87 people (0.27%) have Hepatitis aggravated.

Could Lopressor cause Hepatitis aggravated?

Among these 87 people:

How long have people been on Lopressor when they have Hepatitis aggravated? *

What is the gender of people who have Hepatitis aggravated when taking Lopressor? *

female: 70.24 %
male: 29.76 %

What is the age of people who have Hepatitis aggravated when taking Lopressor? *

What are other drugs people take besides Lopressor? *

What are other side effects people have besides Hepatitis aggravated? *

Weakness: 23 people, 26.44%
Cardiac Failure Congestive: 20 people, 22.99%
Hepatic Failure (liver failure): 20 people, 22.99%
Hypotension (abnormally low blood pressure): 18 people, 20.69%
Acute Kidney Failure: 18 people, 20.69%
Fall: 18 people, 20.69%
Fatigue (feeling of tiredness): 18 people, 20.69%
Osteomyelitis (infection of bone): 16 people, 18.39%
Fever: 16 people, 18.39%
Anaemia (lack of blood): 14 people, 16.09%

What are the existing conditions these people have? *

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 9 people, 10.34%
Osteoporosis (bones weak and more likely to break): 9 people, 10.34%
Depression: 8 people, 9.20%
Pain: 7 people, 8.05%
Multiple Myeloma (cancer of the plasma cells): 7 people, 8.05%
Non-Hodgkin's Lymphoma Stage Iii (malignant (cancer) cells form in the lymph system- stage iii): 5 people, 5.75%
Prothrombin Level Abnormal: 5 people, 5.75%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 5 people, 5.75%
Itching: 4 people, 4.60%
Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 3 people, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Lopressor and have Hepatitis aggravated?

- Check whether Hepatitis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lopressor:

Lopressor (33,152 reports)

Browse all side effects of Lopressor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis aggravated:

Hepatitis aggravated (1,149 drugs)

Browse all the conditions that are associated with Hepatitis aggravated:

Hepatitis aggravated (433 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoprolol tartrate (the active ingredients of Lopressor) and Lopressor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.